AAAAAA

   
Results: 1-20 |
Results: 20
A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases
Authors: Berenson, JR Vescio, RA Rosen, LS VonTeichert, JM Woo, M Swift, R Savage, A Givant, E Hupkes, M Harvey, H Lipton, A
Citation: Jr. Berenson et al., A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases, CLIN CANC R, 7(3), 2001, pp. 478-485
Emergent neuroleptic hypersensitivity as a herald of presenile dementia
Authors: Mendez, MF Lipton, A
Citation: Mf. Mendez et A. Lipton, Emergent neuroleptic hypersensitivity as a herald of presenile dementia, J NEUROP CL, 13(3), 2001, pp. 347-356
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients
Authors: Ali, SM Esteva, FJ Hortobagyi, G Harvey, H Seaman, J Knight, R Costa, L Lipton, A
Citation: Sm. Ali et al., Safety and efficacy of bisphosphonates beyond 24 months in cancer patients, J CL ONCOL, 19(14), 2001, pp. 3434-3437
Bone markers in the management of metastatic bone disease
Authors: Lipton, A Costa, L Ali, SM Demers, LM
Citation: A. Lipton et al., Bone markers in the management of metastatic bone disease, CANC TR REV, 27(3), 2001, pp. 181-185
Update on the role of bisphosphonates in metastatic breast cancer - Introduction
Authors: Lipton, A Coleman, RE Diel, IJ Mundy, G
Citation: A. Lipton et al., Update on the role of bisphosphonates in metastatic breast cancer - Introduction, SEMIN ONCOL, 28(4), 2001, pp. 1-1
Use of markers of bone turnover for monitoring bone metastases and the response to therapy
Authors: Lipton, A Costa, L Ali, S Demers, L
Citation: A. Lipton et al., Use of markers of bone turnover for monitoring bone metastases and the response to therapy, SEMIN ONCOL, 28(4), 2001, pp. 54-59
Zoledronic acid
Authors: Lipton, A
Citation: A. Lipton, Zoledronic acid, DRUGS, 61(6), 2001, pp. 806-806
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases - A double-blind, randomized dose-response study
Authors: Berenson, JR Rosen, LS Howell, A Parter, L Coleman, RE Morley, W Dreicer, R Kuross, SA Lipton, A Seaman, JJ
Citation: Jr. Berenson et al., Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases - A double-blind, randomized dose-response study, CANCER, 91(7), 2001, pp. 1191-1200
Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: A serological search for causation
Authors: Vincent, JM Cherry, JD Nauschuetz, WF Lipton, A Ono, CM Costello, CN Sakaguchi, LK Hsue, G Jackson, LA Tachdjian, R Cotter, PA Gornbein, JA
Citation: Jm. Vincent et al., Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: A serological search for causation, CLIN INF D, 30(3), 2000, pp. 534-539
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
Authors: Hillner, BE Ingle, JN Berenson, JR Janjan, NA Albain, KS Lipton, A Yee, G Biermann, JS Chlebowski, RT Pfister, DG
Citation: Be. Hillner et al., American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer, J CL ONCOL, 18(6), 2000, pp. 1378-1391
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases - Long term follow-up of two randomized, placebo-controlled trials
Authors: Lipton, A Theriault, RL Hortobagyi, GN Simeone, J Knight, RD Mellars, K Reitsma, DJ Heffernan, M Seaman, JJ
Citation: A. Lipton et al., Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases - Long term follow-up of two randomized, placebo-controlled trials, CANCER, 88(5), 2000, pp. 1082-1090
Oral bisphosphonates - A review of clinical use in patients with bone metastases
Authors: Major, PP Lipton, A Berenson, J Hortobagyi, G
Citation: Pp. Major et al., Oral bisphosphonates - A review of clinical use in patients with bone metastases, CANCER, 88(1), 2000, pp. 6-14
Bisphosphonate treatment of lytic bone metastases
Authors: Lipton, A Berenson, JR
Citation: A. Lipton et Jr. Berenson, Bisphosphonate treatment of lytic bone metastases, DRUG AGING, 14(4), 1999, pp. 241-246
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial
Authors: Theriault, RL Lipton, A Hortobagyi, GN Leff, R Gluck, S Stewart, JF Costello, S Kennedy, I Simeone, J Seaman, JJ Knight, RD Mellars, K Heffernan, M Reitsma, DJ
Citation: Rl. Theriault et al., Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial, J CL ONCOL, 17(3), 1999, pp. 846-854
Combined chemoradiotherapy for unresectable pancreatic cancer
Authors: Martin, JL Harvey, HA Lipton, A Martin, R
Citation: Jl. Martin et al., Combined chemoradiotherapy for unresectable pancreatic cancer, AM J CL ONC, 22(3), 1999, pp. 309-314
Antisense oligonucleotides to the epidermal growth factor receptor
Authors: Witters, L Kumar, R Mandal, M Bennett, CF Miraglia, L Lipton, A
Citation: L. Witters et al., Antisense oligonucleotides to the epidermal growth factor receptor, BREAST CANC, 53(1), 1999, pp. 41-50
Bisphosphonates in the treatment of malignant bone disease
Authors: Berenson, JR Lipton, A
Citation: Jr. Berenson et A. Lipton, Bisphosphonates in the treatment of malignant bone disease, ANN R MED, 50, 1999, pp. 237-248
Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma
Authors: Costa, LAM Kopreski, MS Demers, LM Chinchilli, VM Santen, RJ Harvey, HA Lipton, A
Citation: Lam. Costa et al., Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma, CANCER, 85(1), 1999, pp. 100-103
Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription polymerase chain reaction for epidermal growth factor receptor
Authors: Leitzel, K Lieu, B Curley, E Smith, J Chinchilli, V Rychlik, W Lipton, A
Citation: K. Leitzel et al., Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription polymerase chain reaction for epidermal growth factor receptor, CLIN CANC R, 4(12), 1998, pp. 3037-3043
Markers of bone resorption in patients treated with pamidronate
Authors: Lipton, A Demers, L Curley, E Chinchilli, V Gaydos, L Hortobagyi, G Theriault, R Clemens, D Costa, L Seaman, J Knight, R
Citation: A. Lipton et al., Markers of bone resorption in patients treated with pamidronate, EUR J CANC, 34(13), 1998, pp. 2021-2026
Risultati: 1-20 |